CN110183376A - 用于检测人血清白蛋白的荧光探针及其合成方法与应用 - Google Patents
用于检测人血清白蛋白的荧光探针及其合成方法与应用 Download PDFInfo
- Publication number
- CN110183376A CN110183376A CN201910441286.XA CN201910441286A CN110183376A CN 110183376 A CN110183376 A CN 110183376A CN 201910441286 A CN201910441286 A CN 201910441286A CN 110183376 A CN110183376 A CN 110183376A
- Authority
- CN
- China
- Prior art keywords
- dmhp
- fluorescence probe
- hsa
- human serum
- serum albumins
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000523 sample Substances 0.000 title claims abstract description 100
- 210000002966 serum Anatomy 0.000 title claims abstract description 49
- 108010088751 Albumins Proteins 0.000 title claims abstract description 37
- 102000009027 Albumins Human genes 0.000 title claims abstract description 37
- 238000010189 synthetic method Methods 0.000 title claims abstract description 20
- QBEFIFWEOSUTKV-UHFFFAOYSA-N dimethylheptylpyran Chemical compound CC1(C)OC2=CC(C(C)C(C)CCCCC)=CC(O)=C2C2=C1CCC(C)C2 QBEFIFWEOSUTKV-UHFFFAOYSA-N 0.000 claims abstract description 101
- 238000001514 detection method Methods 0.000 claims abstract description 30
- 238000006243 chemical reaction Methods 0.000 claims abstract description 27
- BVSAMCGTEVHSSK-UHFFFAOYSA-M 1-ethyl-4-methylpyridin-1-ium;iodide Chemical compound [I-].CC[N+]1=CC=C(C)C=C1 BVSAMCGTEVHSSK-UHFFFAOYSA-M 0.000 claims abstract description 14
- 238000003384 imaging method Methods 0.000 claims abstract description 9
- 150000003053 piperidines Chemical class 0.000 claims abstract description 8
- 239000003054 catalyst Substances 0.000 claims abstract description 7
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims abstract description 7
- VKTMDTZJPKSAKH-UHFFFAOYSA-N 5-(diethylamino)-2-ethenylphenol Chemical class CCN(CC)c1ccc(C=C)c(O)c1 VKTMDTZJPKSAKH-UHFFFAOYSA-N 0.000 claims abstract description 4
- 238000006482 condensation reaction Methods 0.000 claims abstract description 4
- 238000000034 method Methods 0.000 claims description 21
- 239000002904 solvent Substances 0.000 claims description 16
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 13
- 238000005292 vacuum distillation Methods 0.000 claims description 9
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 8
- -1 1- ethyl Chemical group 0.000 claims description 7
- 235000019441 ethanol Nutrition 0.000 claims description 6
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 4
- 239000012429 reaction media Substances 0.000 claims description 4
- QGBSISYHAICWAH-UHFFFAOYSA-N dicyandiamide Chemical compound NC(N)=NC#N QGBSISYHAICWAH-UHFFFAOYSA-N 0.000 claims description 2
- 239000003550 marker Substances 0.000 claims description 2
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 claims 1
- 238000002474 experimental method Methods 0.000 abstract description 26
- 238000003786 synthesis reaction Methods 0.000 abstract description 9
- 230000035945 sensitivity Effects 0.000 abstract description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 5
- 239000003960 organic solvent Substances 0.000 abstract description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 23
- 210000004027 cell Anatomy 0.000 description 18
- 238000012360 testing method Methods 0.000 description 15
- 238000002189 fluorescence spectrum Methods 0.000 description 14
- 239000000243 solution Substances 0.000 description 13
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- 239000000047 product Substances 0.000 description 11
- 238000004458 analytical method Methods 0.000 description 10
- 230000008569 process Effects 0.000 description 9
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 8
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 8
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 8
- 239000007853 buffer solution Substances 0.000 description 7
- 102000004190 Enzymes Human genes 0.000 description 6
- 108090000790 Enzymes Proteins 0.000 description 6
- 229940088598 enzyme Drugs 0.000 description 6
- 230000004044 response Effects 0.000 description 6
- 239000007864 aqueous solution Substances 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 230000007062 hydrolysis Effects 0.000 description 5
- 238000006460 hydrolysis reaction Methods 0.000 description 5
- 230000002209 hydrophobic effect Effects 0.000 description 5
- 238000001228 spectrum Methods 0.000 description 5
- 229960005080 warfarin Drugs 0.000 description 5
- PJVWKTKQMONHTI-UHFFFAOYSA-N warfarin Chemical compound OC=1C2=CC=CC=C2OC(=O)C=1C(CC(=O)C)C1=CC=CC=C1 PJVWKTKQMONHTI-UHFFFAOYSA-N 0.000 description 5
- ZKHQWZAMYRWXGA-KQYNXXCUSA-N Adenosine triphosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-N 0.000 description 4
- 102000016943 Muramidase Human genes 0.000 description 4
- 108010014251 Muramidase Proteins 0.000 description 4
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 4
- 102000001253 Protein Kinase Human genes 0.000 description 4
- 108010017842 Telomerase Proteins 0.000 description 4
- 239000004202 carbamide Substances 0.000 description 4
- 238000003759 clinical diagnosis Methods 0.000 description 4
- 230000003013 cytotoxicity Effects 0.000 description 4
- 231100000135 cytotoxicity Toxicity 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 229960003180 glutathione Drugs 0.000 description 4
- 229960000274 lysozyme Drugs 0.000 description 4
- 239000004325 lysozyme Substances 0.000 description 4
- 235000010335 lysozyme Nutrition 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 108060006633 protein kinase Proteins 0.000 description 4
- FRPHFZCDPYBUAU-UHFFFAOYSA-N Bromocresolgreen Chemical compound CC1=C(Br)C(O)=C(Br)C=C1C1(C=2C(=C(Br)C(O)=C(Br)C=2)C)C2=CC=CC=C2S(=O)(=O)O1 FRPHFZCDPYBUAU-UHFFFAOYSA-N 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 102000009617 Inorganic Pyrophosphatase Human genes 0.000 description 3
- 108010009595 Inorganic Pyrophosphatase Proteins 0.000 description 3
- 239000003480 eluent Substances 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 238000005160 1H NMR spectroscopy Methods 0.000 description 2
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 2
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 2
- 108010017384 Blood Proteins Proteins 0.000 description 2
- 102000004506 Blood Proteins Human genes 0.000 description 2
- 102000009123 Fibrin Human genes 0.000 description 2
- 108010073385 Fibrin Proteins 0.000 description 2
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 108010024636 Glutathione Proteins 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 238000001460 carbon-13 nuclear magnetic resonance spectrum Methods 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 238000012512 characterization method Methods 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000005611 electricity Effects 0.000 description 2
- 229950003499 fibrin Drugs 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- XJMOSONTPMZWPB-UHFFFAOYSA-M propidium iodide Chemical compound [I-].[I-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CCC[N+](C)(CC)CC)=C1C1=CC=CC=C1 XJMOSONTPMZWPB-UHFFFAOYSA-M 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000008542 thermal sensitivity Effects 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 1
- WAVOOWVINKGEHS-UHFFFAOYSA-N 3-(diethylamino)phenol Chemical compound CCN(CC)C1=CC=CC(O)=C1 WAVOOWVINKGEHS-UHFFFAOYSA-N 0.000 description 1
- 241000208340 Araliaceae Species 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- 206010013710 Drug interaction Diseases 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 1
- 206010029164 Nephrotic syndrome Diseases 0.000 description 1
- 229930012538 Paclitaxel Natural products 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 102000009609 Pyrophosphatases Human genes 0.000 description 1
- 108010009413 Pyrophosphatases Proteins 0.000 description 1
- 108010087230 Sincalide Proteins 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 239000012491 analyte Substances 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 239000000090 biomarker Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 238000010609 cell counting kit-8 assay Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000007882 cirrhosis Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 239000013068 control sample Substances 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- GGSUCNLOZRCGPQ-UHFFFAOYSA-N diethylaniline Chemical group CCN(CC)C1=CC=CC=C1 GGSUCNLOZRCGPQ-UHFFFAOYSA-N 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 238000002848 electrochemical method Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000012894 fetal calf serum Substances 0.000 description 1
- 238000012921 fluorescence analysis Methods 0.000 description 1
- 238000001917 fluorescence detection Methods 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 208000009928 nephrosis Diseases 0.000 description 1
- 231100001027 nephrosis Toxicity 0.000 description 1
- 229960001592 paclitaxel Drugs 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 238000003127 radioimmunoassay Methods 0.000 description 1
- 238000011897 real-time detection Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000027756 respiratory electron transport chain Effects 0.000 description 1
- 229930002330 retinoic acid Natural products 0.000 description 1
- IZTQOLKUZKXIRV-YRVFCXMDSA-N sincalide Chemical compound C([C@@H](C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@@H](N)CC(O)=O)C1=CC=C(OS(O)(=O)=O)C=C1 IZTQOLKUZKXIRV-YRVFCXMDSA-N 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/06—Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1003—Carbocyclic compounds
- C09K2211/1007—Non-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1029—Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
- G01N2021/6432—Quenching
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Optics & Photonics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910441286.XA CN110183376B (zh) | 2019-05-24 | 2019-05-24 | 用于检测人血清白蛋白的荧光探针及其合成方法与应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910441286.XA CN110183376B (zh) | 2019-05-24 | 2019-05-24 | 用于检测人血清白蛋白的荧光探针及其合成方法与应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN110183376A true CN110183376A (zh) | 2019-08-30 |
CN110183376B CN110183376B (zh) | 2022-04-01 |
Family
ID=67717754
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910441286.XA Active CN110183376B (zh) | 2019-05-24 | 2019-05-24 | 用于检测人血清白蛋白的荧光探针及其合成方法与应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110183376B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112745258A (zh) * | 2021-01-22 | 2021-05-04 | 齐鲁工业大学 | 一种高信噪比的线粒体荧光探针及其制备方法与应用 |
CN113307748A (zh) * | 2021-04-27 | 2021-08-27 | 河北大学 | 一种广谱型蛋白质荧光探针及其制备方法和应用 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105018072A (zh) * | 2015-07-08 | 2015-11-04 | 山东理工大学 | 检测人血清白蛋白的荧光探针及其制备方法 |
CN105572095A (zh) * | 2016-03-18 | 2016-05-11 | 南京微瑞莱电子科技有限公司 | 一种人血清白蛋白的检测试剂及定量检测方法 |
US20160209419A1 (en) * | 2013-08-30 | 2016-07-21 | Council Of Scentific & Industrial Research | Squaraine based fluorescent probe and a process for the preparation thereof |
CN106841128A (zh) * | 2016-12-07 | 2017-06-13 | 苏州尚稷电子科技有限公司 | 一类检测人血清白蛋白的高特异性荧光探针的应用 |
CN108484490A (zh) * | 2018-05-23 | 2018-09-04 | 贵州大学 | 检测水中多种金属离子用的荧光探针及其制备方法和应用 |
-
2019
- 2019-05-24 CN CN201910441286.XA patent/CN110183376B/zh active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20160209419A1 (en) * | 2013-08-30 | 2016-07-21 | Council Of Scentific & Industrial Research | Squaraine based fluorescent probe and a process for the preparation thereof |
CN105018072A (zh) * | 2015-07-08 | 2015-11-04 | 山东理工大学 | 检测人血清白蛋白的荧光探针及其制备方法 |
CN105572095A (zh) * | 2016-03-18 | 2016-05-11 | 南京微瑞莱电子科技有限公司 | 一种人血清白蛋白的检测试剂及定量检测方法 |
CN106841128A (zh) * | 2016-12-07 | 2017-06-13 | 苏州尚稷电子科技有限公司 | 一类检测人血清白蛋白的高特异性荧光探针的应用 |
CN108484490A (zh) * | 2018-05-23 | 2018-09-04 | 贵州大学 | 检测水中多种金属离子用的荧光探针及其制备方法和应用 |
Non-Patent Citations (4)
Title |
---|
HU, LING 等: "A small molecule emitting in the near infrared region with pH sensitivity for visualization mitochondria", 《TALANTA》 * |
HUANG, SAI 等: "Trans-4-[4-(dimethylamino)styryl]-1-methylpyridinium Iodide@Hemimethylcucurbit[6]uril Fluorescent Probe for Anion Recognition", 《AUSTRALIAN JOURNAL OF CHEMISTRY》 * |
WANG, FEI 等: "A two-photon mitochondria-targeted fluorescent probe for the detection of pH fluctuation in tumor and living cells", 《DYES AND PIGMENTS》 * |
崔凤灵等: "探针3-(2-氰基乙基)胞嘧啶同步荧光法测定血清中蛋白质", 《光谱学与光谱分析》 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112745258A (zh) * | 2021-01-22 | 2021-05-04 | 齐鲁工业大学 | 一种高信噪比的线粒体荧光探针及其制备方法与应用 |
CN112745258B (zh) * | 2021-01-22 | 2022-09-20 | 齐鲁工业大学 | 一种高信噪比的线粒体荧光探针及其制备方法与应用 |
CN113307748A (zh) * | 2021-04-27 | 2021-08-27 | 河北大学 | 一种广谱型蛋白质荧光探针及其制备方法和应用 |
CN113307748B (zh) * | 2021-04-27 | 2022-06-28 | 河北大学 | 一种广谱型蛋白质荧光探针及其制备方法和应用 |
Also Published As
Publication number | Publication date |
---|---|
CN110183376B (zh) | 2022-04-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Wu et al. | A selective and sensitive fluorescent albumin probe for the determination of urinary albumin | |
Luo et al. | An environment-sensitive fluorescent probe for quantification of human serum albumin: Design, sensing mechanism, and its application in clinical diagnosis of hypoalbuminemia | |
Liang et al. | A lysosome-targetable turn-on fluorescent probe for the detection of thiols in living cells based on a 1, 8-naphthalimide derivative | |
Liu et al. | Solvatochromic fluorescent probes for recognition of human serum albumin in aqueous solution: Insights into structure-property relationship | |
Zhu et al. | A red-emitting fluorescent probe for mitochondria-target microviscosity in living cells and blood viscosity detection in hyperglycemia mice | |
CN106950210B (zh) | 一种检测谷胱甘肽的试剂及其合成方法和应用 | |
CN104974744B (zh) | 一种硫氧还蛋白还原酶荧光探针及其制备方法和用途 | |
CN106432164B (zh) | 一种香豆素衍生物docopa及其制备方法和应用 | |
CN113185506B (zh) | 多信号荧光探针的合成及其在检测Cys、GSH和Hcy中的应用 | |
CN107033111B (zh) | 一种检测硫化氢的近红外荧光探针的合成及应用 | |
CN108329302A (zh) | 一种硫化物特异性响应的半花菁类近红外荧光探针化合物及其制备方法和应用 | |
CN110183376A (zh) | 用于检测人血清白蛋白的荧光探针及其合成方法与应用 | |
CN106749034A (zh) | 对亚硫酸氢根和次氯酸根双响应比率型荧光标记试剂及其合成方法和应用 | |
Xiao et al. | A dansyl-based fluorescent probe for the highly selective detection of cysteine based on a d-PeT switching mechanism | |
CN110615786B (zh) | 用于检测粘度的近红外荧光化合物及其制备与应用 | |
KR20160135105A (ko) | 선형 업컨버전 형광 특성을 이용한 생체물질 검출 방법 | |
CN105503768B (zh) | alpha‑酮戊二酸的荧光/紫外分子探针的制备方法及其在生物样本中的应用 | |
CN104198740A (zh) | 一种对葡萄糖和胆固醇同步检测的纳米生物传感器 | |
Kavyashree et al. | Rationally designed far-red emitting styryl chromones and a magnetic nanoconjugate for strip-based ‘on-site’detection of metabolic markers | |
CN107973836A (zh) | 醛固酮衍生物及其制备方法、醛固酮均相酶免疫检测试剂 | |
Xu et al. | A highly selective probe for ratiometric imaging peroxynitrite in living cells and in vivo | |
CN103116025A (zh) | 一种时间分辨荧光法综合检测胃癌试剂盒及其应用 | |
CN115490674A (zh) | 选择性检测同型半胱氨酸的荧光探针的合成及应用 | |
CN108593905A (zh) | 一种地高辛免疫检测试剂及其制备和检测方法 | |
CN114295569A (zh) | 半花菁分子光学探针在检测亚硫酸氢根的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20230726 Address after: 201600 No.13 and No.14, Lane 5398, Shenzhuan Road, Dongjing Town, Songjiang District, Shanghai Patentee after: SHANGHAI GENERAY BIOTECH CO.,LTD. Address before: Room 518, No. 91 Kefeng Road, Huangpu District, Guangzhou City, Guangdong Province, 510700 (office only) Patentee before: Guangzhou Fangwei Information Technology Co.,Ltd. Effective date of registration: 20230726 Address after: Room 518, No. 91 Kefeng Road, Huangpu District, Guangzhou City, Guangdong Province, 510700 (office only) Patentee after: Guangzhou Fangwei Information Technology Co.,Ltd. Address before: No.99, Songling Road, Laoshan District, Qingdao City, Shandong Province Patentee before: QINGDAO University OF SCIENCE AND TECHNOLOGY |
|
TR01 | Transfer of patent right |